These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 484564)

  • 1. Effect of control programs on cefazolin prescribing in a teaching hospital.
    Ma MY; Goldstein EJ; Meyer RD
    Am J Hosp Pharm; 1979 Aug; 36(8):1055-8. PubMed ID: 484564
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of a preprinted chart note on appropriate cefazolin prescribing.
    Haas CE; Paladino JA; Dibona JR
    Am J Hosp Pharm; 1986 Jul; 43(7):1754-6. PubMed ID: 3752116
    [No Abstract]   [Full Text] [Related]  

  • 3. Contribution of clinical pharmacists to cefazolin utilization.
    Witte KW; Hatoum HT; Hoon TJ
    Hosp Formul; 1987 Aug; 22(8):737-41. PubMed ID: 10283405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a two-stage intervention program on cefazolin usage at a major teaching hospital.
    Gupta S; Bachand RL; Jewesson PJ
    Hosp Formul; 1989 Jan; 24(1):41-4, 46. PubMed ID: 10291599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effective management of DUE (drug utilization evaluation) policy through a pharmacy clerkship.
    Julius HC
    Hosp Formul; 1993 Sep; 28(9):789-91. PubMed ID: 10128394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacy involvement in a surgery preadmission program.
    Bhanji AA; Fallon KM; LeBlanc SP
    Am J Hosp Pharm; 1993 Mar; 50(3):483-6. PubMed ID: 8442467
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacy U.R. cuts costs, drug use.
    Mosier RL
    Hosp Peer Rev; 1979 May; 4(5):70-2. PubMed ID: 10308905
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost savings achieved through cephalosporin use review and restriction.
    Dzierba SH; Reilly RT; Caselnova DA
    Am J Hosp Pharm; 1986 Sep; 43(9):2194-7. PubMed ID: 3766571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacist impact on parenteral cephalosporin prescribing.
    Lawlor MC; Lucarotti RL
    Hosp Formul; 1983 Apr; 18(4):402-4, 407-8. PubMed ID: 10259512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoglycoside usage in a university teaching hospital.
    Noble MA; Lloyd N; Andrews D; Bernstein M; Sacks S
    Can J Hosp Pharm; 1986 Aug; 39(4):88-91. PubMed ID: 10278472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a triplicate prescription law on prescribing of Schedule II drugs.
    Sigler KA; Guernsey BG; Ingrim NB; Buesing AS; Hokanson JA; Galvan E; Doutré WH
    Am J Hosp Pharm; 1984 Jan; 41(1):108-11. PubMed ID: 6695926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes of house physicians concerning various antibiotic-use control programs.
    Murray MD; Kohler RB; McCarthy MC; Main JW
    Am J Hosp Pharm; 1988 Mar; 45(3):584-8. PubMed ID: 3369461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost benefit of pharmacist concurrent monitoring of cefazolin prescribing.
    Suzuki NT; Pelham LD
    Am J Hosp Pharm; 1983 Jul; 40(7):1187-91. PubMed ID: 6410913
    [No Abstract]   [Full Text] [Related]  

  • 14. Benefits of clinical pharmacy services in a community hospital.
    Williams LE
    Hosp Pharm; 1993 Aug; 28(8):759-63, 766-7. PubMed ID: 10127576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Filling and refilling practices with diazepam and methyldopa.
    Scrivens JJ; Weber C; Sather M; Geck W
    Hosp Formul; 1979 Sep; 14(9):830-1,834-6,838. PubMed ID: 10243909
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of an antibiotic cost containment measure.
    Jung B; Andrews JD
    Can J Hosp Pharm; 1990 Jun; 43(3):116-22. PubMed ID: 10105649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter survey of cefazolin usage.
    Steckel SD; Siskin SB
    Hosp Formul; 1981 Nov; 16(11):1284-6, 1291-3. PubMed ID: 10253176
    [No Abstract]   [Full Text] [Related]  

  • 18. Maintaining current hospital formularies throughout the institution.
    Puglisi RC
    Hosp Pharm; 1978 Mar; 13(3):137, 140. PubMed ID: 10306925
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of a P & T Committee letter to influence dosing.
    Lipman AG
    Hosp Formul; 1987 Mar; 22(3):309, 312. PubMed ID: 10281732
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of education on cephalosporin prescribing patterns.
    Frye CB; Baker B; Sexton DJ; Dougherty FK
    J Okla State Med Assoc; 1987 Sep; 80(9):649-53. PubMed ID: 3668708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.